Patents by Inventor Kishor M. Wasan

Kishor M. Wasan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PROTEASOME INHIBITORS IN THE TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20240115588
    Abstract: Oral formulations comprising one or more proteasome inhibitors for use as a treatment of coronavirus infection in a subject. Also disclosed are the use of such for the treatment or prevention of SARS-CoV-2 infection in humans.
    Type: Application
    Filed: February 1, 2022
    Publication date: April 11, 2024
    Applicants: Board of Supervisors of Louisiana state University and Agricultural and Mechanical College, Skymount Medical US lnc.
    Inventors: Adam Bess, Frej Knut Gosta BERGLIND, Supratik MUKHOPADHYAY, Kishor M. WASAN, Chris GALLIANO, Michal BRYLINSKI, Stephania CORMIER, Allan ADER, Nicholas GRIGGS, Janet GOULD, Tiffany CHO, Julia ABRAMOV, Peter HNIK
  • METHODS OF TREATING CORONAVIRUS DISEASE AND COMPOUNDS FOR SAME
    Publication number: 20230398114
    Abstract: A tyrosine kinase inhibitor for use in the treatment of COVID-19 and/or its associated symptoms. Also disclosed is a method of treating an individual infected with a coronavirus, wherein said method comprises the steps of: providing a tyrosine kinase inhibitor; and administering said tyrosine kinase inhibitor to said individual in a dosage amount sufficient to prevent/stabilize/reduce the risks and/or symptoms associated with a coronavirus infection.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 14, 2023
    Inventors: Kishor M. WASAN, Chris GALLIANO, Supratik MUKHOPADHYAY, Adam BESS, Frej Knut Gosta BERGLIND, Stephania CORMIER, Allan ADER, Nicholas GRIGGS, Janet GOULD, Tiffany CHO, Julia ABRAMOV, Peter HNIK, Michal BRYLINSKI
  • MUCOADHESIVE LIPIDIC DELIVERY SYSTEM
    Publication number: 20210267890
    Abstract: Methods and compositions for enhancing an immune response, such as a mucosal immune response, to a selected antigen are described. The methods are useful for the treatment and prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites.
    Type: Application
    Filed: September 20, 2019
    Publication date: September 2, 2021
    Inventors: Ellen K. Wasan, Kishor M. Wasan, Volker Gerdts, Stacy Strom
  • Modified release formulations of mycophenolate mofetil
    Patent number: 10835489
    Abstract: The present application discloses modified release mucoadhesive formulations of mycophenolate mofetil and pharmaceutical compositions thereof useful in the treatment of, for example, post-transplant organ rejection. Method of preparing the formulations is also disclosed.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: November 17, 2020
    Assignee: University of Saskatchewan
    Inventors: Ellen K. Wasan, Ahmed Shoker, Holly G. Mansell, Kishor M. Wasan
  • MODIFIED RELEASE FORMULATIONS OF MYCOPHENOLATE MOFETIL
    Publication number: 20190274950
    Abstract: The present application discloses modified release mucoadhesive formulations of mycophenolate mofetil and pharmaceutical compositions thereof useful in the treatment of, for example, post-transplant organ rejection. Method of preparing the formulations is also disclosed.
    Type: Application
    Filed: March 4, 2019
    Publication date: September 12, 2019
    Applicant: University of Saskatchewan
    Inventors: Ellen K. Wasan, Ahmed Shoker, Holly G. Mansell, Kishor M. Wasan
  • STABILIZED FORMULATION FOR ORAL ADMINISTRATION OF THERAPEUTIC AGENTS AND RELATED METHODS
    Publication number: 20140228309
    Abstract: Stable formulations for the oral administration of therapeutic agents, methods for administering therapeutic agents using the formulations, and methods for treating conditions and diseases using the formulations.
    Type: Application
    Filed: January 31, 2014
    Publication date: August 14, 2014
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Kishor M. Wasan, Ellen K. Wasan
  • FORMULATIONS FOR THE ORAL ADMINISTRATION OF THERAPEUTIC AGENTS AND RELATED METHODS
    Publication number: 20140228308
    Abstract: Formulations for the oral administration of therapeutic agents, methods for administering therapeutic agents using the formulations, and methods for treating conditions and diseases using the formulations.
    Type: Application
    Filed: November 22, 2013
    Publication date: August 14, 2014
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Kishor M. Wasan, Ellen K. Wasan
  • Stabilized formulation for oral administration of therapeutic agents and related methods
    Patent number: 8673866
    Abstract: Stable formulations for the oral administration of therapeutic agents, methods for administering therapeutic agents using the formulations, and methods for treating conditions and diseases using the formulations.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: March 18, 2014
    Assignee: The University of British Columbia
    Inventors: Kishor M. Wasan, Ellen K. Wasan
  • Formulations for the oral administration of therapeutic agents and related methods
    Patent number: 8592382
    Abstract: The present application relates to an oral formulation of amphotericin B and other therapeutic agents, which formulation comprises one or more fatty acid glycerol esters and one or more PEG modified phospholipids or fatty acid esters. The formulation provides enhanced bioavailability and/or increased stability of the therapeutic agent at the low pH found in gastric fluid.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: November 26, 2013
    Assignee: The University of British Columbia
    Inventors: Kishor M. Wasan, Ellen K. Wasan
  • STABILIZED FORMULATION FOR ORAL ADMINISTRATION OF THERAPEUTIC AGENTS AND RELATED METHODS
    Publication number: 20120270822
    Abstract: Stable formulations for the oral administration of therapeutic agents, methods for administering therapeutic agents using the formulations, and methods for treating conditions and diseases using the formulations.
    Type: Application
    Filed: April 25, 2012
    Publication date: October 25, 2012
    Applicant: UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Kishor M. Wasan, Ellen K. Wasan
  • Formulations For The Oral Administration of Therapeutic Agents and Related Methods
    Publication number: 20100273728
    Abstract: The present application relates to an oral formulation of amphotericin B and other therapeutic agents, which formulation comprises one or more fatty acid glycerol esters and one or more PEG modified phospholipids or fatty acid esters. The formulation provides enhanced bioavailability and/or increased stability of the therapeutic agent at the low pH found in gastric fluid.
    Type: Application
    Filed: May 23, 2008
    Publication date: October 28, 2010
    Inventors: Kishor M. Wasan, Ellen K. Wasan
  • Novel structures and compositions comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease, its underlying conditions including hyperlipidemia and other disorders having inflammation as part of their aetiology or presentation
    Publication number: 20040236125
    Abstract: The present invention provides, in one aspect, novel derivatives comprising sterols and/or stanols and an NSAID selected from salicylic acids and arylalkanoic acids, including salts of these derivatives, and having one or more of the following formulae: 1
    Type: Application
    Filed: September 25, 2002
    Publication date: November 25, 2004
    Applicant: FORBES MEDI-TECH INC.
    Inventors: James P. Kutney, P. Haydn Pritchard, Yanbing Ding, Kishor M. Wasan